Skip to search formSkip to main contentSkip to account menu

PF 00337210

Known as: PF-00337210, PF00337210 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzofuransQuinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Pharmacodynamically guided dose selection of PF-00337210, a VEGFR2 tyrosine kinase (TK) inhibitor, in a phase I study.
3033 Background: PF-00337210 is a highly potent and selective ATP-competitive inhibitor of VEGFR2 TK with a cellular IC50 of 0.8… 
2009
2009
Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PF-00337210, a highly selective VEGFR inhibitor.
3519 Background: PF-00337210 potently inhibits VEGFR2 phosphorylation and is >10-fold more selective, based on IC50, for VEGFR2… 
2007
2007
PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2
3992 PF-00337210 is a potent, selective, and orally bioavailable small molecule inhibitor of VEGFRs. It is an ATP-competitive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)